What is SALL4 ?

SALL4 is an oncofetal protein essential for early development and later causes cancer.

A key stem cell factor, SALL4 has well-known functions in embryonic and fetal development of various organs such as brain and limbs

Key Function

A tumor driver, not merely a tumor marker. SALL4 transgenic mice develop liver and blood cancers; SALL4 knockout resistant to tumor formation

Mechanism

Transcription factor with 4 zinc finger domains and 2 major protein isoforms

Structure

Given the labs’ world renowned expertise in SALL4 and oncoprotein research, we are uniquely positioned to lead the effort in therapeutic targeting.

SALL4 PEPTIDE INHIBITOR SHOWS UNPRECEDENTED INHIBITION OF TUMOR GROWTH IN HCC MODEL

BPY-1: Therapeutic peptide inhibitor with high potency

High Potency : 23 nanoMolar IC50

Small molecular weight : 10 amino acids core strucutre

Nuclear envelope permeability: Linked to a cell/nuclear penetration sequence

Excellent target affinity: Covers the shallow binding pocket between RBBP4 (chaperone subunit of NuRD) And SALL4

Patents filed and granted

We believe in drugging the undruggable.

We founded Believer pharmaceuticals with the aim to revolutionize cancer precision medicine, by targeting the novel SALL4 transcription factor oncogenic pathway.

BELIEVER

in the NEWS

Nucleate Boston 2023 Activator
MIT Media Lab Event
2023 HBS New Venture Competition

We are presenting at the Nucleate Summit!

We hope to see you there.